Thomas Kolombe

A Prospective, Randomized, Open-Label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee

Philipp Niemeyer, Volker Laute, Wolfgang Zinser et al. · Orthopaedic Journal of Sports Medicine · 2019 · 84 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial

Christoph Becher, Volker Laute, Stefan Fickert et al. · Journal of Orthopaedic Surgery and Research · 2017 · 61 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

The Effect of Cell Dose on the Early Magnetic Resonance Morphological Outcomes of Autologous Cell Implantation for Articular Cartilage Defects in the Knee

Philipp Niemeyer, Volker Laute, Thilo John et al. · The American Journal of Sports Medicine · 2016 · 59 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Matrix-Associated Autologous Chondrocyte Implantation with Spheroid Technology Is Superior to Arthroscopic Microfracture at 36 Months Regarding Activities of Daily Living and Sporting Activities after Treatment

Arnd Hoburg, Philipp Niemeyer, Volker Laute et al. · Cartilage · 2020 · 46 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years

Philipp Niemeyer, Volker Laute, Wolfgang Zinser et al. · Knee Surgery Sports Traumatology Arthroscopy · 2020 · 42 citations

Engineering, Bioengineering, Orthopaedic Surgery +16